Royal DSM N.V., headquartered in Heerlen, The Netherlands, announced that it has reached principal agreement with Shanghai Pharmaceutical Group (SPG) in Shanghai, Peoples Republic of China to acquire the equity interests of SPG in the joint venture between DSM and SPG, named Roche (Shanghai) Vitamins Limited (RSVL). After this acquisition of the 36 % share participation of SPG, RSVL will be a wholly owned subsidiary of DSM (Nutritional Products) and in due course will be renamed DSM Vitamins (Shanghai) Ltd.
According to the agreement signed between DSM and SPG, DSM will acquire the equity interest held by SPG in Roche (Shanghai) Vitamins Limited for the sum of approximately 10 million Euro. With this step DSM further strengthens its position in the Chinese vitamin market.
Share:
